Nextage Therapeutics Ltd

TLV • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/26/2026

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeTLV

Market Capitalization30.72 mln

Float66.19 mln

Piotroski F-Score

4 / 9

Borderline

Beneish M-Score

0.56

Highly suspicious

Relative Strength

2 / 100

Severely lagging

Debt / Equity

0.84

Moderate leverage

Pre-Tax Margin

-636%

Severely loss-making

ROE

-81.23

Deeply negative

Business Description

Founded in 1982 and headquartered in Ness Ziona, Israel, Nextage Therapeutics Ltd researches and produces medicines derived from cannabinoids for patients both in Israel and around the world.

Key Fundamentals

EPS-0.31

ROE-81.23

RPS0.04

ROIC-19.14

ROA-34.45

Interest Cover-3.23

EBITDA, mln-10.58

EV / EBITDA-5.26

EV / EBIT-4.58

Revenue, mln2.51

EV / Revenue22.16

Quote Details

Last 31.70

Change -5.7 (-15.24%)

Open 40.80

Volume 127,313

Turnover 4,035,822

Average Volume 62,808

Financial Ratios

Pre-Tax Profit Margin-636

Leverage Ratio1.90

Current Ratio0.06

Price / Book1.47

Debt / Equity0.84

Price / Sales11.54

Financial Strength

Altman Z-Score-2.49

Piotroski F-Score 4 / 9

Beneish M-Score0.56

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-13.15%	1 / 100
1 Month	-18.51%	4 / 100
2 Months	-22.68%	10 / 100